Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches

Ciprian Tomuleasa, Cristina Selicean, Sonia Cismas, Anca Jurj, Mirela Marian, Delia Dima, Sergiu Pasca, Bobe Petrushev, Vlad Moisoiu, Wilhelm-Thomas Micu, Anna Vischer, Kanza Arifeen, Sonia Selicean, Mihnea Zdrenghea, Horia Bumbea, Alina Tanase, Ravnit Grewal, Laura Pop, Carmen Aanei, Ioana Berindan-Neagoe
  • Critical Reviews in Clinical Laboratory Sciences, May 2018, Taylor & Francis
  • DOI: 10.1080/10408363.2018.1463508

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/10408363.2018.1463508

The following have contributed to this page: Dr Alina D Tanase, Mrs Laura T Pop, and KANZA ARIFEEN